A5057753158- Diabetes Management and Research
- Pituitary Gland Disorders and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Lipoproteins and Cardiovascular Health
- Diabetes and associated disorders
- Growth Hormone and Insulin-like Growth Factors
- Diabetes Treatment and Management
- Diet and metabolism studies
- Pancreatic function and diabetes
- Metabolism, Diabetes, and Cancer
- Adrenal Hormones and Disorders
- Adrenal and Paraganglionic Tumors
- Blood Pressure and Hypertension Studies
- Adipose Tissue and Metabolism
- Cancer, Lipids, and Metabolism
- Cardiovascular Health and Disease Prevention
- Vitamin K Research Studies
- Hormonal Regulation and Hypertension
- Stress Responses and Cortisol
- Estrogen and related hormone effects
- Pharmaceutical Economics and Policy
- Pharmaceutical Practices and Patient Outcomes
- Glioma Diagnosis and Treatment
- Hormonal and reproductive studies
- Reproductive Health and Contraception
Group for the Analysis of Development
2023-2025
Rainier Clinical Research Center
2025
Neuroscience Institute
2016-2017
Swedish Medical Center
2016-2017
University of Louisville
2016
Neurological Surgery
2016
University of Washington
1994-2001
University of Iowa
1996
Northwest University
1996
Pacific Biomarkers (United States)
1996
Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the management of insulin-treated 2 diabetes. In this 13-week, multicenter trial, adults diabetes were randomly assigned a 2:1 ratio receive AID or continue pretrial insulin-delivery method (control group); both groups received continuous glucose monitoring (CGM). The primary outcome was glycated hemoglobin...
OBJECTIVE Successful transsphenoidal surgery for adrenocorticotropin hormone (ACTH)–producing pituitary tumors is associated with subnormal postoperative serum cortisol levels, which may guide decisions regarding immediate reoperation. However, little known about the detailed temporal course of changes in period, and relationship dynamics to remission late recurrence. METHODS A single-center retrospective cohort analysis was performed all patients undergoing from 2007 through 2015....
This study examined whether psychological stress and the infusion of epinephrine increase plasma lipid apoprotein concentrations in normolipidemic hyperlipidemic men. Subjects were studied during three separate 6-hour laboratory sessions: a control session, which subjects rested quietly while blood samples hemodynamic measurements obtained; presented with two challenging mental tasks, followed by quiet rest; an received low-dose rest. The manipulations produced expected changes...
BACKGROUND: Atorvastatin, a new HMG-CoA reductase inhibitor in clinical development has demonstrated an acceptable safety profile and marked cholesterol triglyceride reduction at doses ranging from 10-80 mg/day. Since bile acid sequestering resins are often used combination with HMGRIs to enhance reduction, this trial was conducted explore the use of atorvastatin alone combined colestipol patients primary hyperlipidemia. METHODS AND RESULTS: One hundred six low-density lipoprotein (LDL) >4.1...
OBJECTIVE: To determine the efficacy and safety of pravastatin in treatment subjects with Type III hyperlipoproteinemia. DESIGN: Randomized, double-blind, placebo-controlled, crossover study. SETTING: Four lipid research clinics United States. PATIENTS: Twenty between 18 70 years old three diagnostic features hyperlipoproteinemia: very-low-density lipoprotein cholesterol (VLDL-C)/total plasma triglyceride ratio excess 0.30; beta-migrating VLDL pattern on agarose-gel electrophoresis;...
The urinary free cortisol (UFC) test is widely used for the screening of Cushing's syndrome. This case study illustrates potential failure UFC to correctly diagnose disease (CD), indicating that use other complementary tests may be necessary this in some cases. (CD) a condition characterized by elevation levels caused an ACTH-secreting pituitary adenoma. Failure accurately identify and treat patients with could lead increased risk mortality worsened morbidity compared control population....
Objective: Pasireotide is approved for treatment of adults with Cushing disease (CD) persistent hypercortisolism whom surgery has failed or not an option. Effective medical therapy CD may increase the susceptibility relative hypocortisolism during acute stress because a patient's inability to compensate by increasing endogenous adrenocorticotropic hormone (ACTH) and cortisol secretion. We describe patient on pasireotide 7 years in biochemical eucortisolemia was achieved but subsequently...
Heinonen, Therese M; Schrott, Helmut; Broyles, Frances; Shurzinske, Linda; Black, Donald M Author Information